Andrew Rappaport - 05 Mar 2024 Form 4 Insider Report for Olema Pharmaceuticals, Inc. (OLMA)

Role
Director
Signature
/s/ Shane Kovacs, Attorney-in-Fact
Issuer symbol
OLMA
Transactions as of
05 Mar 2024
Net transactions value
$0
Form type
4
Filing time
06 Mar 2024, 17:36:05 UTC
Previous filing
21 Jun 2023
Next filing
18 Jun 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OLMA Common Stock Other $0 -481,014 -100% $0.000000* 0 05 Mar 2024 See Footnote F1, F2
transaction OLMA Common Stock Other $0 +385,965 $0.000000 385,965 05 Mar 2024 See Footnote F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Pro rata distribution for no consideration from SPW Investments LLC ("SPWI") to its members. Skyline Public Works, LLC, of which the Reporting Person is a managing member, is the general partner of SPWI.
F2 The shares were held by SPWI.
F3 The shares are held by the Rappaport Family Trust, of which the reporting person is co-trustee.